Managing acid reflux involves lifestyle adjustments to reduce symptoms and prevent discomfort. Strengthening the lower esophageal sphincter can help prevent acid from rising into the esophagus. Avoiding smoking,…
Ulcerative colitis is a chronic inflammatory bowel disease that affects the colon and rectum, causing symptoms like abdominal pain, bloody diarrhea, rectal urgency, and fatigue. Sanjay Murthy, MD,…
Larry Smarr, PhD, Founding Director of of CALIT2, ushers in a new era of medicine with 3D visualization software as well as 3D printing. This technology will revolutionize…
NEW YORK (Reuters Health) – Among patients undergoing liver transplantation for hepatocellular carcinoma, the risk of recurrence is lower when immunosuppression is based on sirolimus rather than calcineurin…
NEW YORK (Reuters Health) – Adding the anti-VEGF monoclonal antibody bevacizumab to FOLFOX chemotherapy does not improve outcomes in patients with stage II-III colon cancer, according to a…
NEW YORK (Reuters Health) – Sorafenib delivered concurrently with transarterial chemoembolization (TACE) is safe in patients with intermediate hepatocellular cancer and does not lead to any unexpected adverse…
NEW YORK (Reuters Health) – In patients with liver cancer related to hepatitis B virus (HBV) infection, giving nucleoside analogues after curative surgery appears to reduce the risk…
NEW YORK (Reuters Health) – Even the best strategies for selectively testing colorectal CRC tumors for mismatch repair (MMR) gene mutations will miss 5% to 15% of Lynch…
NEW YORK (Reuters Health) – A retrospective multicenter study conducted in France concludes that combination chemotherapy with gemcitabine and oxaliplatin is effective in patients with advanced hepatocellular carcinoma…
NEW YORK (Reuters Health) – In the first-line treatment of advanced colorectal cancer, the combination of cediranib and chemotherapy is comparable to bevacizumab plus chemotherapy in terms of…
Ambulatory surgical centers (ASC) are facilities that aim to combine the best healthcare providers, the latest medical equipment, and the most efficient outpatient services. Leslie Seecoomar, MD, describes how expanding…
NEW YORK (Reuters Health) – There is “sufficient” evidence that treatment with a proton-pump inhibitor (PPI) increases the incidence of Clostridium-difficile-associated diarrhea (CDAD), say the authors of a…
